Mebendazole Competitive Antibody Pair

AccuSift
MBZ
SKU Name Unit Price Delivery QTY
SR237 Mebendazole monoclonal antibody 1mg $750 10days
TC237 Mebendazole BSA antigen 1mg $300 10days
AccuSift provides high-performance Mebendazole competitive assay pairings, characterized by exceptional batch-to-batch consistency and optimized for IVD kit development (Lateral Flow, Chemiluminescence, ELISA, POCT). These pairings offer high affinity and specificity, facilitating rapid detection.

Mebendazole is a broad-spectrum anthelmintic drug with significant larvicidal and ovicidal activity. Both in vivo and in vitro studies demonstrate that it directly inhibits glucose uptake by nematodes, leading to glycogen depletion and reduced ATP production, ultimately causing parasite death. It does not affect blood glucose levels in humans. Ultrastructural observations show that mebendazole induces microtubule degeneration in the tegumental and intestinal cells of the parasites, resulting in the accumulation of secretory granules in the Golgi apparatus, transport blockage, cytoplasmic autolysis, and complete cellular degeneration, leading to the death of the parasite.
Performance Characteristics:

Sensitivity: ELISA IC50: 5 ppb

Cross-Reactivity: Fenbendazole 5 ppb, Oxfendazole 5 ppb, Oxfendazole sulfone 5 ppb, Albendazole 100 ppb

Source: Mouse Monoclonal Antibody

Purity: ≥ 90%

Recommended Pairing: (Coating) / (Labeling)

Storage: Long-term storage at ≤ -20°C; short-term storage at 2-8°C. Shipped on ice packs.


Operation

References